Assignee
VENENUM BIODESIGN LLC
US·8 granted patents·2 pending applications·7 citations·filing 2017–2022
Top patents by PatentIndex Score
10 records- 0187US11306098B2Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitorsVENENUM BIODESIGN LLC·Filed 2020·Granted Apr 19, 2022·3 cites·13 claims
- 0281US10654834B2Non-systemic TGR5 agonistsVENENUM BIODESIGN LLC·Filed 2017·Granted May 19, 2020·3 cites·20 claims
- 0374US11583538B2Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitorsVENENUM BIODESIGN LLC·Filed 2020·Granted Feb 21, 2023·1 cites·22 claims
- 0466US11883420B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2021·Granted Jan 30, 2024·0 cites·4 claims
- 0565US11161864B2Sting agonistsVENENUM BIODESIGN LLC·Filed 2019·Granted Nov 2, 2021·0 cites·18 claims
- 0663US11110106B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2020·Granted Sep 7, 2021·0 cites·20 claims
- 0761US2022213111A1Substituted heterocycles as cyclic trex1 inhibitorsVENENUM BIODESIGN LLC·Filed 2022·Application pending·0 cites
- 0861US2022048936A1Novel sting agonistsVENENUM BIODESIGN LLC·Filed 2021·Application pending·0 cites
- 0941US11236055B2Non-systemic TGR5 agonistsVENENUM BIODESIGN LLC·Filed 2017·Granted Feb 1, 2022·0 cites·23 claims
- 1039US10669242B2Clostridium difficile toxin inhibitorsVENENUM BIODESIGN LLC·Filed 2017·Granted Jun 2, 2020·0 cites·27 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →